Foresite Capital Management V, LLC Alx Oncology Holdings Inc Transaction History

Foresite Capital Management V, LLC

  • $47 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$52.51 - $80.91 $12.1 Million - $18.7 Million
-231,200 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$52.2 - $75.23 $4.64 Million - $6.68 Million
-88,800 Reduced 27.75%
231,200 $12.6 Million
Q4 2020

Feb 16, 2021
BUY
$34.11 - $112.26 $10.9 Million - $35.9 Million
320,000 New
320,000 $27.6 Million

Others Institutions Holding ALXO

# of Institutions
117
Shares Held
40.7M
Call Options Held
518K
Put Options Held
142K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $57M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Foresite Capital Management V, LLC Portfolio

Follow Foresite Capital Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management V, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email